Authors
Latest:
Inflation Reduction Act and Its Impact on Pharmaceutical Pricing and Investment DecisionsThe reference to “maximum fair price” in the act bodes poorly for manufacturers and suggests more of a take-it-or-leave-it situation rather than a negotiation where clinical evidence would be the prevailing factor in determining price.
Latest:
HIV Care Creates Opportunities for Pharmacists to Expand ScopeIn the most recent episode of Over the Counter, Jay Holloway, PharmD, AAHIVP, discussed advancements in HIV, especially regarding the role of pharmacists.
Latest:
How Vitamin D Can Help Migraines In Young PatientsVitamin D supplementation may be an effective and safe adjunctive prophylactic therapy to topiramate for children who experience migraine attacks, showed a study conducted in Saudi Arabia.
Latest:
Holistic Treatment Techniques for Managing Atopic DermatitisPatients are finding relief in alternative therapies for this chronic skin disease.
Latest:
Racial, Ethnic Inequities Persist in Diabetes CareSignificant differences in the use of insulin pump and/or CGM technology were noted based on demographic and socioeconomic factors
Latest:
Bosutinib Approved by FDA for Pediatric Chronic Myelogenous LeukemiaPositive findings from the phase 1/2 BCHILD study supported the approval decision.
Latest:
FDA Requests Black Box Warning for Approved CAR-T Therapies Over Secondary Cancer ConcernAs per US law Section 505(o)(4), the manufacturers are required to make the requested changes, respond with a modified version of the requested changes for review, or respond with a rebuttal within 30 days of the FDA's ask.
Latest:
COVID-19 Vaccination Rates Significantly Lower in Patients With Sickle Cell DiseasePatients with SCD are more vulnerable to hospitalization due, in part, to SCD’s impact on the spleen, which filters infections in the blood and is a crucial organ for the immune system.
Latest:
Advanced Health Care Technology Solutions Can Help Both Providers and PayersIntegrating evidence-based treatment protocols through a streamlined approach enables the delivery of higher quality, comprehensive care.
Latest:
Veterinary Prescriptions Made EasyHow can e-prescribing improve the workflow between pharmacists and their veterinarian colleagues?
Latest:
How to Balance Your Time in the PharmacyA shift in mindset and priorities can help you improve staff performance, acquire new patients, and leverage technology for more efficient operations.
Latest:
IQVIA Predicts Biosimilar, Generic Competition Will Cost Originators $192 Billion by 2028According to the most recent Global Use of Medicine report issued by the IQVIA Institute for Human Data Science, losses for originator products are projected to rise by over $80 billion over the next 5 years due to market introductions of new biosimilar and generic drugs.
Latest:
Opicapone Can Help Treat Patients Experiencing “Off” Episodes With Parkinson DiseaseLevodopa/carbidopa is currently the gold standard for controlling motor symptoms associated with Parkinson disease.
Latest:
Cancer Risk Associated With UV Nail DryersThe safety of gel manicures is under renewed scrutiny after a new study suggested they can cause DNA damage
Latest:
College Students and Misuse of SubstancesThe prevalence of annual alcohol consumption is highest in full-time college students 1 to 4 years after high school.
Latest:
How Vitamin D Can Help Migraines In Young PatientsVitamin D supplementation may be an effective and safe adjunctive prophylactic therapy to topiramate for children who experience migraine attacks, showed a study conducted in Saudi Arabia.
Latest:
Nirsevimab Demonstrates Lasting Efficacy in Infants Through First RSV SeasonThe drug, marketed as Beyfortus, was approved by the FDA in July for the prevention of RSV lower respiratory tract disease (LRTD) in newborns and infants born during or entering their first RSV season, and for children up to 24 months of age who remain vulnerable to severe RSV disease through their second RSV season.
Latest:
Cannabis Legalization's Impact on Prenatal Marijuana UseFindings from a study in JAMA Network Open reveal valuable insight into the way cannabis legalization has impacted the perceptions of pregnant women who use cannabis in the US.
Latest:
A Partnership to Optimize Medication Use and Patient OutcomesInitiative promotes adoption of value-based care models in community pharmacy settings.
Latest:
Vaccine Additive Strengthens Immune Response, Offers Possibilities for Universal Flu VaccineBy adding an adjuvant to an existing vaccine treatment, it’s possible to optimize the body’s response to the presence of a virus.
Latest:
Mind-Body Resilience for Women: A Focus on DepressionDeveloping innovative solutions for women with depression, accounting for differences in gender and sex, are critically important
Latest:
Latest on Pediatric Depression TreatmentsFurther evidence-based antidepressant treatments are needed for children and adolescents with depression.
Latest:
Wildfire Smoke Associated With Worse NSCLC Survival Rates After Surgical ResectionWildfire smoke is a considerable contributor to air pollution, with wildfire smoke exposure consistently associated with respiratory morbidity including lung cancer risk.
Latest:
How to Engage With Elected Officials When You Can't Meet Face to FaceUntil social distancing measures are phased out, store owners who want to make a difference in independent pharmacy can and should leverage technology to connect with legislators virtually.
Latest:
Education is Key to Improving Hepatitis B Vaccination RatesResources with pertinent information are essential in motivating individuals to comply with vaccine recommendations.
Latest:
Discussing the Current Landscape of PBM Reform LegislationDuring an interview, Joseph Shields of TransparencyRx discusses the PBM legislation that is expected to move forward in Congress in the next few months.
Latest:
College Students and Misuse of SubstancesThe prevalence of annual alcohol consumption is highest in full-time college students 1 to 4 years after high school.
Latest:
First-in-Class Treatment for Obstructive Hypertrophic Cardiomyopathy Is Approved by FDAMavacamten improves functional capacity and symptoms in adults with New York Heart Association class II-III obstructive HCM.
